A South Georgia girl is asking the community for help to provide scholarships for college-bound young women. In February, Madison Daughtry was named the Distinguished Young Woman of Leesburg for theMore >>
In February, Madison Daughtry was named the Distinguish Young Woman of Leesburg for the Class of 2014.More >>
Sunday, May 19 2013 6:16 PM EDT2013-05-19 22:16:35 GMT
The Tift County Sheriff's investigators are still searching for clues to find a missing pregnant woman. Her mother is making a plea to find her daughter who hasn't been seen in more than two months. DianeMore >>
The Tift County Sheriff's investigators are still searching for clues to find Crystal Hendrix. Her mother is making a plea to find her daughter who hasn't been seen in more than two months.More >>
Sunday, May 19 2013 10:19 AM EDT2013-05-19 14:19:32 GMT
A Lowndes County man is behind bars after deputies uncovered nearly half a million dollars of marijuana. Deputies responded to a complaint at Jose Sanchez's house on Highway 129 North Friday. AuthoritiesMore >>
A Lowndes County man is behind bars after deputies uncovered nearly half a million dollars of marijuana.
Saturday, May 18 2013 11:42 PM EDT2013-05-19 03:42:03 GMT
Hundreds of people came out to Lake Blackshear Saturday to support law enforcement and the Crisp County Sheriff. It was the first annual pigs in the park event, put on by the Georgia Narcotics Officer'sMore >>
Hundreds of people came out to Lake Blackshear Saturday to support law enforcement and the Crisp County Sheriff.More >>
Saturday, May 18 2013 9:47 PM EDT2013-05-19 01:47:12 GMT
Thomasville Police are looking for two men who attempted to rob a store, scaring customers and clerks. Police say they responded to the Dollar General on West Jackson Street around 9:15pm Friday. EmployeesMore >>
Thomasville Police are looking for two men who attempted to rob a store, scaring customers and clerks.
Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
NEW YORK, Feb. 18, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Respiratory syncytial virus (RSV) is a leading cause of infant/childhood lower respiratory tract infection and hospitalization. Elderly adults and those with underlying co-morbidities such as chronic obstructive pulmonary disease (COPD) or suffering with malignancies are also at increased risk of RSV infection related complications. RSV is estimated to be responsible for ~9,000 deaths per year (US).
An RSV prophylactic vaccine would ideally to reduce the incidence of severe RSV lower respiratory tract infections in "at risk" groups. Currently a number of approaches are being pursued including live-attenuated viruses and/or recombinant proteins, the most advanced of which is AstraZeneca/Medimmune's MEDI-534 and MEDI-559. US biotech Novavax have also completed a Phase I trial with VLP recombinant RSV-F fusion protein.
This MarketVIEW is a comprehensive MS Excel-based model + summary presentation which forecasts the potential commercial value of new RSV vaccines across global markets to 2030. The model contains value ($ m) and volume (mio doses) predictions for infants (
<1yrs) and various adult target groups. Differing RSV vaccine profiles (infant + elderly) and related issues such as differential pricing are also discussed with regard to LO/BASE/HI market uptake scenarios. >THIS PRODUCT IS A SUMMARY PRESENTATION + MODEL Executive summaryCommercial model – key outputsTotal predicted demand (doses 000s), all scenariosTotal global available market ($000s), all scenariosTotal global available market ($000s), infantTotal global available market ($000s), adult "at risk"Total global available market ($000s), adult "universal"The role of a RSV vaccineVaccine target populations: overviewVaccine target populations: scenario definitionsRSV vaccine: infant target product profileRSV vaccine: adult target product profileMarkets included in the modelCommercial model assumptions: infant scenarioCommercial model assumptions: adult scenariosModel forecast comparisons: March 2010 v current model (May 2012)Pricing methodology: infant and adultsCompetitor landscape overviewMedImmune: MEDI-534 and MEDI-559 vaccinesNovavax: VLP RSV-F vaccineNovavax: Phase I dataPreclinical vaccinesVaccine pipeline summaryEstimated launch datesOpportunities for new treatmentsReview of latest epidemiologyEpidemiology: infantsEpidemiology: adultsEpidemiology: hospitalizationsMethodology: target populationsMethodology: coverageModel forecast comparisons: Novavax/LEK analysisBibliographyAbout VacZine AnalyticsDisclaimerPAGES: 60 MS PowerPoint slides, fully referenced/sourced. Available in .pdf formContents – Vaccine demand model (MS Excel-based)Title sheetScenarion definitionsGRAND SUMMARY CHARTSCHARTS VALUECHARTS VOLUMECHARTS VOLUME – HIGHVALUE SUMMARY – universalVALUE SUMMARY – "at risk"VALUE SUMMARY – infantsVOLUME SUMMARY – universalVOLUME SUMMARY – "at risk"VOLUME SUMMARY – infantsCountry volume/population sheetsUSCanadaUKGermanyFranceSpainItalyOther EUJapanBrazilIndiaChinaMexicoCountry total populations – forecast to 2030 (Births, >18 yrs, >65 yrs)Source materialUS RSVJapan RSVUS PneumoniaAsthma/COPD epidemiologyCHF epidemiologyCancer EPIPricing (infant)Coverage (COPD and HF)Back pageAbout VacZine AnalyticsDisclaimerWORKSHEETS: ~65